Candriam Equities L Biotech.C-H EUR Acc/ LU1120766206 /
| NAV23/05/2024 | Var.-3.4200 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 194.2700EUR | -1.73% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | 4.50 | 1.83 | -5.03 | 10.78 | 0.59 | 4.26 | -10.61 | -11.54 | 7.84 | 3.34 | 0.40 | +4.26% |
| 2016 | -23.30 | -4.50 | 3.68 | 3.70 | 5.38 | -8.64 | 12.35 | -2.51 | 3.83 | -12.88 | 9.14 | -3.00 | -20.47% |
| 2017 | 5.33 | 6.69 | -0.05 | 0.89 | -3.15 | 9.22 | 2.21 | 6.71 | 0.69 | -6.82 | -0.16 | 1.27 | +24.05% |
| 2018 | 6.44 | -4.86 | -2.41 | -3.43 | 4.27 | 0.55 | 4.17 | 3.82 | -2.27 | -14.27 | 3.77 | -8.62 | -14.03% |
| 2019 | 12.76 | 3.32 | -0.89 | -5.21 | -4.74 | 9.15 | -2.47 | -2.55 | -4.76 | 10.91 | 11.78 | 2.49 | +30.88% |
| 2020 | -5.47 | -1.64 | -5.49 | 12.16 | 9.41 | 1.19 | -3.05 | 0.74 | 0.56 | -2.77 | 9.29 | 2.82 | +17.10% |
| 2021 | 1.73 | -2.65 | -4.44 | 2.62 | -2.35 | 6.25 | -1.54 | 3.80 | -4.36 | 0.09 | -4.46 | 2.24 | -3.71% |
| 2022 | -10.71 | -1.69 | 5.75 | -7.90 | -4.17 | 3.06 | 4.53 | 1.25 | -2.38 | 6.14 | 5.87 | -3.28 | -5.21% |
| 2023 | 2.66 | -5.87 | 0.05 | 2.69 | -1.17 | 1.20 | -0.77 | -0.42 | -4.65 | -6.26 | 5.89 | 13.33 | +5.25% |
| 2024 | 1.37 | 1.17 | -0.16 | -6.40 | 3.80 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 15.87% | 17.14% | 16.23% | 20.05% | 22.64% |
| Indice di Sharpe | -0.32 | 1.66 | -0.05 | -0.16 | 0.11 |
| Mese migliore | +13.33% | +13.33% | +13.33% | +13.33% | +13.33% |
| Mese peggiore | -6.40% | -6.40% | -6.40% | -10.71% | -10.71% |
| Perdita massima | -11.27% | -11.27% | -16.45% | -30.33% | -32.47% |
| Outperformance | +0.20% | - | +1.23% | -7.79% | -6.03% |
Tutte le quotazioni in EUR
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,029.3600 | +6.16% | +10.12% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 216.7100 | +4.70% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,032.9000 | +3.88% | +2.44% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,186.5100 | +5.62% | +24.17% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,350.8601 | +3.68% | +20.80% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 351.4100 | +3.73% | +24.57% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 319.7600 | +5.67% | +26.71% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 197.8500 | +1.41% | +0.72% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,815.4800 | +6.41% | +12.88% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 147.0600 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 590.2400 | +4.83% | +7.94% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,552.8198 | +6.06% | +9.73% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 194.2700 | +3.02% | +1.95% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.5900 | +3.91% | +4.46% | |
| Candriam Equities L Biotech.R US... | reinvestment | 263.1400 | +6.14% | +12.03% | |
| Candriam Equities L Biotechnolo... | reinvestment | 828.5400 | +5.22% | +9.31% | |
| Candriam Equities L Biotechnolog... | paying dividend | 756.6900 | +5.19% | +9.20% |
Prestazione
| YTD | -0.52% | ||
|---|---|---|---|
| 6 mesi | +14.80% | ||
| 1 anno | +3.02% | ||
| 3 anni | +1.95% | ||
| 5 anni | +35.14% | ||
| 10 anni | - | ||
| Dall'inizio | +29.51% | ||
| Anno | |||
| 2023 | +5.25% | ||
| 2022 | -5.21% | ||
| 2021 | -3.71% | ||
| 2020 | +17.10% | ||
| 2019 | +30.88% | ||
| 2018 | -14.03% | ||
| 2017 | +24.05% | ||
| 2016 | -20.47% | ||
| 2015 | +4.26% | ||
